Details
Stereochemistry | RACEMIC |
Molecular Formula | C26H28Cl2N4O4 |
Molecular Weight | 531.431 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
InChI
InChIKey=XMAYWYJOQHXEEK-ZEQKJWHPSA-N
InChI=1S/C26H28Cl2N4O4/c1-19(33)31-10-12-32(13-11-31)21-3-5-22(6-4-21)34-15-23-16-35-26(36-23,17-30-9-8-29-18-30)24-7-2-20(27)14-25(24)28/h2-9,14,18,23H,10-13,15-17H2,1H3/t23-,26-/m1/s1
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QG01AF11
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
KETOCONAZOLE HRA (AUTHORIZED: CUSHING SYNDROME)
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
||
|
WHO-ATC |
D01AC08
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
||
|
FDA ORPHAN DRUG |
51990
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
||
|
WHO-VATC |
QJ02AB02
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
||
|
NDF-RT |
N0000175487
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
||
|
WHO-VATC |
QD01AC08
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
||
|
LIVERTOX |
NBK547869
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
||
|
WHO-ATC |
G01AF11
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
||
|
NDF-RT |
N0000008217
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
||
|
WHO-ATC |
J02AB02
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/17/1857
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
||
|
NCI_THESAURUS |
C2018
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
65277-42-1
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | |||
|
DB01026
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | |||
|
KETOCONAZOLE
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | |||
|
SUB08373MIG
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | |||
|
CHEMBL295698
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | |||
|
6135
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | RxNorm | ||
|
Ketoconazole
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | |||
|
4594
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | |||
|
100000092078
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | |||
|
47519
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | |||
|
KETOCONAZOLE
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | Description: A white or almost white powder. Solubility: Practically insoluble in water; freely soluble in dichloromethane R; soluble in methanol R; sparingly soluble in ethanol (~750 g/l) TS. Category: Antifungal drug. Storage: Ketoconazole should be kept in a well-closed container, protected from light. Requirement: Ketoconazole contains not less than 99.0% and not more than the equivalent of 101.0% of C26H28Cl2N4O4, calculated with reference to the dried substance. | ||
|
R9400W927I
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | |||
|
2568
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | |||
|
7447
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | |||
|
m6619
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | Merck Index | ||
|
R9400W927I
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | |||
|
N0000190115
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | Cytochrome P450 3A5 Inhibitors [MoA] | ||
|
317629
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | |||
|
N0000182141
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | Cytochrome P450 3A4 Inhibitors [MoA] | ||
|
47576
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | |||
|
1527
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | |||
|
N0000185503
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | P-Glycoprotein Inhibitors [MoA] | ||
|
79156-75-5
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
265-667-4
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | |||
|
1356508
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | |||
|
DTXSID7029879
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | |||
|
D007654
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY | |||
|
C605
Created by
admin on Fri Dec 15 18:05:27 UTC 2023 , Edited by admin on Fri Dec 15 18:05:27 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
METABOLITE INACTIVE (PARENT)
METABOLITE INACTIVE (PARENT)
METABOLITE INACTIVE (PARENT)